ranitidine
25 mg/ml
True
10605

Ranitidine

Ranitidine (Zantac) 25 mg/ml Prices, Discount Comparisons & Savings Options

Ranitidine (Zantac) 25 mg/ml discount prices range from per pill or unit. Before you buy ranitidine, compare the lowest discounted ranitidine prices at U.S. pharmacies and PharmacyChecker-accredited international online pharmacies.

FDA Update - September 2019

Over-the-counter ranitidine is used to treat and prevent heartburn caused by acid indigestion. It works by decreasing the amount of acid made in the stomach. Prescription strength ranitidine is used to treat ulcers caused by gastroesophageal reflux disease (GERD), which is a condition where the stomach makes too much acid.

The U.S. Food and Drug Administration (FDA) has discovered that some ranitidine medicines, such as the brand-name drug Zantac, contain low levels of a nitrosamine impurity called N-nitrosodimethylamine (NDMA). According to the FDA, NDMA is known as a substance which could cause cancer in humans. NDMA is a known environmental contaminant in the US and found in water, vegetables, dairy products, and meats. The FDA is working with regulators around the world to determine the direct source of the ranitidine impurity.

The FDA is not asking for patients to stop taking ranitidine at this time. Patients taking OTC ranitidine do have the option of switching to another OTC medication. For patients taking prescription ranitidine please consult your healthcare provider before discontinuing.

The Italian Drug Agency stated they are recalling all versions of ranitidine containing an active ingredient made by Saraca Laboratories, a manufacturer based in India. They are still testing for impurities with other manufacturers.

Health Canada has requested that companies stop distributing ranitidine drugs in Canada while they assess the NDMA impurities. The page to this notice seems down but you can check back at a later time here.

The European Medicines Agency is currently evaluating data to assess if patients using ranitidine are at a risk from NDMA impurities and will provide information about this as soon. They are working on guidance for avoiding nitrosamines. Check here for updates.

The Drugs Standard Control Organization (CDSCO) of India is currently investigating a probable presence of NDMA in ranitidine and has advised state regulators to verify products and take appropriate measures to ensure patient safety.
We advise patients to check with their providers and/or pharmacists for any updates on possible recalls of ranitidine, and to discuss other treatment options, if necessary.

U.S. FDA Ranitidine Statement

Health Canada Ranitidine Statement

EMA Ranitidine Press Release

Currently Viewing

Generic

Also See

Brand
Pharmacy Savings Option
Quantity

FDA Update - September 2019

Over-the-counter ranitidine is used to treat and prevent heartburn caused by acid indigestion. It works by decreasing the amount of acid made in the stomach. Prescription strength ranitidine is used to treat ulcers caused by gastroesophageal reflux disease (GERD), which is a condition where the stomach makes too much acid.

The U.S. Food and Drug Administration (FDA) has discovered that some ranitidine medicines, such as the brand-name drug Zantac, contain low levels of a nitrosamine impurity called N-nitrosodimethylamine (NDMA). According to the FDA, NDMA is known as a substance which could cause cancer in humans. NDMA is a known environmental contaminant in the US and found in water, vegetables, dairy products, and meats. The FDA is working with regulators around the world to determine the direct source of the ranitidine impurity.

The FDA is not asking for patients to stop taking ranitidine at this time. Patients taking OTC ranitidine do have the option of switching to another OTC medication. For patients taking prescription ranitidine please consult your healthcare provider before discontinuing.

The Italian Drug Agency stated they are recalling all versions of ranitidine containing an active ingredient made by Saraca Laboratories, a manufacturer based in India. They are still testing for impurities with other manufacturers.

Health Canada has requested that companies stop distributing ranitidine drugs in Canada while they assess the NDMA impurities. The page to this notice seems down but you can check back at a later time here.

The European Medicines Agency is currently evaluating data to assess if patients using ranitidine are at a risk from NDMA impurities and will provide information about this as soon. They are working on guidance for avoiding nitrosamines. Check here for updates.

The Drugs Standard Control Organization (CDSCO) of India is currently investigating a probable presence of NDMA in ranitidine and has advised state regulators to verify products and take appropriate measures to ensure patient safety.
We advise patients to check with their providers and/or pharmacists for any updates on possible recalls of ranitidine, and to discuss other treatment options, if necessary.

U.S. FDA Ranitidine Statement

Health Canada Ranitidine Statement

EMA Ranitidine Press Release

The total price includes shipping fees which typically cover an entire order, making it more economical to purchase multiple medications in the same order.

U.S. government officials have stated that individuals who order non-controlled prescription drugs from Canada or other foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted - although it is technically not legal for individuals to import most prescription drugs. The U.S FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in other countries. Read how regulations may differ by country.

Find Discounted Prices at Local U.S. Pharmacies

Select Quantity

ZIP Code

Sign up for PharmacyChecker News

Exclusive drug savings tips & news straight to your inbox.

PharmacyChecker uses cookies to track & improve your online experience.